Merck
MRK
#54
Rank
A$384.31 B
Marketcap
A$155.60
Share price
2.73%
Change (1 day)
20.56%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): A$11.23

According to Merck's latest financial reports the company's current EPS (TTM) is A$10.14. an increase over its 2024 EPS that were of A$9.38.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025A$10.107.71%
2024A$9.384308.46%
2023A$0.21-97.32%
2022A$7.9510.92%
2021A$7.1784.68%
2020A$3.88-27.2%
2019A$5.3363.44%
2018A$3.26151.11%
2017A$1.30-54.58%
2016A$2.8630.21%
2015A$2.20-61.99%
2014A$5.78180.51%
2013A$2.06-31.82%
2012A$3.026.62%
2011A$2.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.45 52.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$9.99-1.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.89-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.20-48.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$31.94 214.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$19.88 96.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.86-71.75%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$4.80-52.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.23-48.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$1.72-83.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel